Business Description
KNC Laboratories Co Ltd
ISIN : JP3290400005
Share Class Description:
TSE:6568: Ordinary SharesTotal Employee Number:
321Compare
Compare
Traded in other countries / regions
6568.Japan7LW.Germany IPO Date
2018-03-15Description
KNC Laboratories Co Ltd is an organic chemical and biochemical manufacturing company.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.6 | |||||
Equity-to-Asset | 0.65 | |||||
Debt-to-Equity | 0.26 | |||||
Debt-to-EBITDA | 1.57 | |||||
Interest Coverage | 29.74 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 2.09 | |||||
Beneish M-Score | -3.05 | |||||
WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 1.7 | |||||
3-Year EBITDA Growth Rate | -9.7 | |||||
3-Year EPS without NRI Growth Rate | -21 | |||||
3-Year Book Growth Rate | 6.1 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 20.9 | |||||
9-Day RSI | 38.63 | |||||
14-Day RSI | 47.17 | |||||
3-1 Month Momentum % | -0.48 | |||||
6-1 Month Momentum % | 2.82 | |||||
12-1 Month Momentum % | 13.23 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.87 | |||||
Quick Ratio | 1.66 | |||||
Cash Ratio | 0.8 | |||||
Days Inventory | 166.5 | |||||
Days Sales Outstanding | 69.75 | |||||
Days Payable | 21.24 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 2.5 | |||||
Dividend Payout Ratio | 0.33 | |||||
3-Year Dividend Growth Rate | 5.6 | |||||
Forward Dividend Yield % | 2.5 | |||||
5-Year Yield-on-Cost % | 3.45 | |||||
3-Year Average Share Buyback Ratio | -0.1 | |||||
Shareholder Yield % | -5.71 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 26.26 | |||||
Operating Margin % | 11.27 | |||||
Net Margin % | 8.43 | |||||
EBITDA Margin % | 25.22 | |||||
FCF Margin % | -4 | |||||
OCF Margin % | 24.88 | |||||
ROE % | 5.6 | |||||
ROA % | 3.69 | |||||
ROIC % | 4.3 | |||||
3-Year ROIIC % | -11.2 | |||||
ROC (Joel Greenblatt) % | 6.92 | |||||
ROCE % | 5.83 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 13.1 | |||||
PE Ratio without NRI | 13.12 | |||||
Shiller PE Ratio | 10.73 | |||||
Price-to-Owner-Earnings | 8.48 | |||||
PEG Ratio | 2.26 | |||||
PS Ratio | 1.1 | |||||
PB Ratio | 0.71 | |||||
Price-to-Tangible-Book | 0.72 | |||||
Price-to-Operating-Cash-Flow | 4.44 | |||||
EV-to-EBIT | 10.8 | |||||
EV-to-EBITDA | 5 | |||||
EV-to-Revenue | 1.26 | |||||
EV-to-FCF | -32.24 | |||||
Price-to-GF-Value | 1 | |||||
Price-to-Projected-FCF | 1.32 | |||||
Price-to-Peter-Lynch-Fair-Value | 2.28 | |||||
Price-to-Graham-Number | 0.65 | |||||
| Price-to-Net-Current-Asset-Value | 40.49 | |||||
Earnings Yield (Greenblatt) % | 9.26 | |||||
FCF Yield % | -3.63 | |||||
Forward Rate of Return (Yacktman) % | 5.31 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
KNC Laboratories Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil 円) | 9,093.706 | ||
| EPS (TTM) (円) | 98.971 | ||
| Beta | 0.3345 | ||
| 3-Year Sharpe Ratio | -0.56 | ||
| 3-Year Sortino Ratio | -0.7 | ||
| Volatility % | 19.35 | ||
| 14-Day RSI | 47.17 | ||
| 14-Day ATR (円) | 26.039926 | ||
| 20-Day SMA (円) | 1321.55 | ||
| 12-1 Month Momentum % | 13.23 | ||
| 52-Week Range (円) | 1060 - 1418 | ||
| Shares Outstanding (Mil) | 7.74 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
KNC Laboratories Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
KNC Laboratories Co Ltd Stock Events
| Event | Date | Price (円) | ||
|---|---|---|---|---|
| JPY 16.000000 Cash Dividend | 2026-09-29 | In 74 days | ||
| JPY 17.000000 Cash Dividend | 2026-03-30 | 1,273.00 (+1.19%) | ||
| JPY 16.000000 Cash Dividend | 2025-09-29 | 1,166.00 (-0.17%) | ||
| JPY 17.000000 Cash Dividend | 2025-03-28 | 1,108.00 (+0.82%) | ||
| JPY 16.000000 Cash Dividend | 2024-09-27 | 1,124.00 (-2.85%) |
Show
Entries
KNC Laboratories Co Ltd Frequently Asked Questions
What is KNC Laboratories Co Ltd(TSE:6568)'s stock price today?
The current price of TSE:6568 is 円1296.00. The 52 week high of TSE:6568 is 円1418.00 and 52 week low is 円1060.00.
When is next earnings date of KNC Laboratories Co Ltd(TSE:6568)?
The next earnings date of KNC Laboratories Co Ltd(TSE:6568) is .
Does KNC Laboratories Co Ltd(TSE:6568) pay dividends? If so, how much?
The Dividend Yield %  of KNC Laboratories Co Ltd(TSE:6568) is 2.5% (As of Today), Highest Dividend Payout Ratio of KNC Laboratories Co Ltd(TSE:6568) was 1087.81. The lowest was 0.14. And the median was 0.29. The  Forward Dividend Yield % of KNC Laboratories Co Ltd(TSE:6568) is 2.5%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on KNC Laboratories Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers